Effective systemic therapy for the treatment of stage III melanoma has emerged. Whether this influences treatment choice in stage III melanoma patients with in-transit metastases is the subject of this review.
Cornelis Verhoef, MD, PhD
Advertisement
Articles by Cornelis Verhoef, MD, PhD
Advertisement
Latest Updated Articles
Isolated Limb Perfusion for Stage III Melanoma: Does It Still Have a Role in the Present Era of Effective Systemic Therapy?Published: December 15th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
2
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC
3
Career Stage and Location Found to Impact Oncology Coverage in the US
4
Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC
5
